Compare LULU & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LULU | ALC |
|---|---|---|
| Founded | 1998 | 1945 |
| Country | Canada | Switzerland |
| Employees | N/A | N/A |
| Industry | Apparel | Ophthalmic Goods |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.9B | 39.4B |
| IPO Year | 2007 | N/A |
| Metric | LULU | ALC |
|---|---|---|
| Price | $207.62 | $78.73 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 26 | 12 |
| Target Price | ★ $220.40 | $88.71 |
| AVG Volume (30 Days) | ★ 4.4M | 1.7M |
| Earning Date | 12-11-2025 | 11-11-2025 |
| Dividend Yield | N/A | ★ 0.27% |
| EPS Growth | ★ 4.42 | N/A |
| EPS | ★ 14.48 | 2.10 |
| Revenue | ★ $11,073,296,000.00 | $10,185,000,000.00 |
| Revenue This Year | $5.67 | $5.79 |
| Revenue Next Year | $4.41 | $7.36 |
| P/E Ratio | ★ $14.15 | $36.85 |
| Revenue Growth | ★ 8.76 | 4.34 |
| 52 Week Low | $159.25 | $71.55 |
| 52 Week High | $423.32 | $99.20 |
| Indicator | LULU | ALC |
|---|---|---|
| Relative Strength Index (RSI) | 72.94 | 52.90 |
| Support Level | $180.00 | $78.55 |
| Resistance Level | $191.85 | $80.39 |
| Average True Range (ATR) | 6.28 | 1.21 |
| MACD | 1.95 | -0.03 |
| Stochastic Oscillator | 80.83 | 47.42 |
Lululemon Athletica designs, distributes, and markets athletic apparel, footwear, and accessories for women, men, and girls. The company offers pants, shorts, tops, and jackets for both leisure and athletic activities such as yoga and running. Lululemon also sells fitness accessories, such as bags, yoga mats, and equipment. It sells its products through digital channels, a small number of wholesale partners, more than 780 company-owned stores in about two dozen countries in North America, Asia, and Western Europe, and about 40 franchised locations in the Middle East and Europe. The company was founded in 1998 and is based in Vancouver, Canada.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.